Pancreatic cancer
Results
Phase 1
This trial looked at a treatment called all-trans retinoic acid (ATRA) for pancreatic cancer. It was for people whose cancer had grown into surrounding tissue or spread to another part of the body.
The trial was open for people to join between 2016 and 2018. The team published the results in 2020.
Recruitment start: 20 January 2016
Recruitment end: 27 February 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Hemant Kocher Dr David Propper
Medical Research Council (MRC)
Celgene Corporation
NIHR Clinical Research Network: Cancer
Barts Health NHS Trust
Queen Mary University of London
Last reviewed: 26 January 2024
CRUK internal database number: 13611
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
